NCT06068348
Active, not recruiting
Not Applicable
Collection of Human Blood for Development of Liquid Biopsy Assay
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chaperonin-Containing TCP-1
- Sponsor
- University of Central Florida
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- To determine if the biomarker, Chaperonin-Containing TCP-1 (CCT), can be used to detect circulating tumor cells (CTC) in blood.
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
The purpose of this study is to develop a liquid biopsy approach for detection of circulating tumor cells (CTC) that could be used in place of the more invasive and potentially risky methods of tissue biopsy. The aims of the project are: (a) determine whether the Chaperonin-Containing TCP-1 (CCT) chaperonin can used to identify rare cancer cells in blood, and (b) establish whether the cancer cells detected using the CCT chaperonin for identification have invasive or metastatic potential.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male or female
- •Age greater than or equal to 18 and less than or equal to 80 years.
Exclusion Criteria
- •Adults unable to give informed consent
- •Individuals who are not yet adults (infants, children, teenagers; under the age of 18)
- •Individuals who weigh less than 110 lbs (as standard clinically advised to not give blood)
- •Pregnant women (due to hormonal changes in blood)
- •Prisoners
- •Persons reporting a current microbial (bacterial, viral, or fungal) infections
- •Persons reporting that they are current taking antibiotic medications
- •Persons with body temperatures above 99oF (indicating a fever)
Outcomes
Primary Outcomes
To determine if the biomarker, Chaperonin-Containing TCP-1 (CCT), can be used to detect circulating tumor cells (CTC) in blood.
Time Frame: 3 years
Secondary Outcomes
- To determine if the CCT chaperonin can provide information on the metastatic potential of CTC.(3 years)
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung CancerHealthyPulmonary NoduleNCT04156360Shanghai Pulmonary Hospital, Shanghai, China150
Recruiting
Not Applicable
Neurofibromatosis Type 1 Tumor Early Detection StudyNeurofibromatosis Type 1Neurofibromatosis 1Plexiform NeurofibromaPlexiform NeurofibromasMalignant Peripheral Nerve Sheath TumorMalignant Peripheral Nerve Sheath TumorsAtypical NeurofibromaNCT06515860David Miller1,000
Completed
Not Applicable
Collection of Blood Specimens for Circulating Tumor Cell AnalysisBreast CancerProstate CancerColorectal CancerNCT01943500Viatar LLC14
Unknown
Not Applicable
Breast Cancer Liquid Biopsy TrialBreast CancerCancerNCT04962529Anthony Magliocco450
Recruiting
Not Applicable
Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA ChipHead and Neck Cancers- Squamous CellHead and Neck Cancer MetastaticRecurrent Head and Neck Squamous Cell CarcinomaNCT06678724National Taiwan University Hospital30